Boryung Corporation (KRX:003850)

Market Cap	707.81B
Revenue (ttm)	1.02T
Net Income (ttm)	46.58B
Shares Out	83.96M
EPS (ttm)	637.03
PE Ratio	13.23
Forward PE	11.35
Dividend	100.00 (1.20%)
Ex-Dividend Date	Dec 27, 2024

Volume	74,377
Average Volume	236,039
Open	8,510.00
Previous Close	8,430.00
Day's Range	8,460.00 - 8,630.00
52-Week Range	7,680.00 - 12,870.00
Beta	0.60
RSI	49.17
Earnings Date	Jul 29, 2025

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.